In breast cancer, GIPC1 can facilitate cell proliferation, survival, and invasion via signaling pathways such as the AKT/Mdm2/p53 and insulin-like growth factor 1-induced extracellular signal-regulated kinase (ERK)1/2 signaling pathways [36,37]. This evidence concerns the gene TP53 and breast carcinoma.